APA (7th ed.) Citation

E, L., O, J., R, S., N, B., TS, J., P, S., . . . BA, W. (2025). Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroups. Genome medicine, 17(1), 79. https://doi.org/10.1186/s13073-025-01503-y

Chicago Style (17th ed.) Citation

E, Liu, et al. "Utilizing Genomics to Identify Novel Immunotherapeutic Targets in Multiple Myeloma High-risk Subgroups." Genome Medicine 17, no. 1 (2025): 79. https://doi.org/10.1186/s13073-025-01503-y.

MLA (9th ed.) Citation

E, Liu, et al. "Utilizing Genomics to Identify Novel Immunotherapeutic Targets in Multiple Myeloma High-risk Subgroups." Genome Medicine, vol. 17, no. 1, 2025, p. 79, https://doi.org/10.1186/s13073-025-01503-y.